Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
239.60
-0.70 (-0.29%)
At close: May 23, 2025
-13.13%
Market Cap 5.31B
Revenue (ttm) 293.64M
Net Income (ttm) -362.30M
Shares Out n/a
EPS (ttm) -16.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 240.30
Day's Range n/a
52-Week Range 239.60 - 301.70
Beta n/a
RSI 41.45
Earnings Date Aug 5, 2025

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.